Taysha Gene Therapies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TSHA research report →
About the company
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS).
- CEO
- Sean Nolan
- IPO
- 2020
- Employees
- 73
- HQ
- Dallas, TX, US
Price Chart
- Market Cap
- $1.63B
- P/E
- -17.06
- P/S
- 190.46
- P/B
- 11.30
- EV/EBITDA
- -9.02
- Div Yield
- 0.00%
- Gross Margin
- 88.22%
- Op Margin
- -1774.37%
- Net Margin
- -1738.40%
- ROE
- -56.07%
- ROIC
- -47.30%
- Revenue
- $9.77M · 17.28%
- Net Income
- $-108,995,000 · -22.06%
- EPS
- $-0.34 · 5.56%
- Op Income
- $-110,498,000
- FCF YoY
- -14.99%
- 52W High
- $7.30
- 52W Low
- $2.33
- 50D MA
- $6.17
- 200D MA
- $5.04
- Beta
- 1.16
- Avg Volume
- 3.05M
Get TickerSpark's AI analysis on TSHA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 1, 26 | Stalfort John A III | other | 21,335 |
| Jun 1, 26 | Stalfort John A III | other | 42,671 |
| Jun 1, 26 | Donenberg Phillip B. | other | 21,335 |
| Jun 1, 26 | Donenberg Phillip B. | other | 42,671 |
| Jun 1, 26 | Long Alison S | other | 21,335 |
| Jun 1, 26 | Long Alison S | other | 42,671 |
| Jun 1, 26 | Sepp-Lorenzino Laura | other | 21,335 |
| Jun 1, 26 | Sepp-Lorenzino Laura | other | 42,671 |
| Apr 10, 26 | Nagendran Sukumar | other | 19,021 |
| Apr 10, 26 | Nagendran Sukumar | sell | 200,000 |
Our TSHA coverage
Recent articles, reports, and earnings notes.
No research on TSHA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TSHA report →Similar companies
Peers in the same neighborhood.